0001604665false00016046652024-11-052024-11-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): November 5, 2024

Westlake Chemical Partners LP
(Exact name of registrant as specified in its charter)

Delaware001-3656732-0436529
(State or other jurisdiction
of incorporation)		(Commission File Number)(I.R.S. Employer
Identification No.)
2801 Post Oak Boulevard,Suite 60077056
Houston,Texas
(Address of principal executive offices)(Zip Code)
Registrant's telephone number, including area code: (713) 585-2900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common units representing limited partnership interestsWLKPThe New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻







Item 2.02. Results of Operations and Financial Condition.
On November 5, 2024, Westlake Chemical Partners LP (the "Partnership") issued a press release announcing its 2024 third quarter results. A copy of the press release is furnished with this Current Report as Exhibit 99.1.
The information furnished pursuant to this Current Report, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and will not be incorporated by reference into any filing by Westlake Chemical Partners LP under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, unless specifically identified as being incorporated therein.
Item 7.01. Regulation FD Disclosure.
The Partnership is holding a conference call on November 5, 2024 to discuss its 2024 third quarter results. Information about the call can be found in the press release furnished with this Current Report as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following exhibit is furnished herewith:
104    The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

WESTLAKE CHEMICAL PARTNERS LP
By: Westlake Chemical Partners GP LLC
Date:November 5, 2024By:
/S/ JEAN-MARC GILSON
Jean-Marc Gilson
President, Chief Executive Officer and Director







EXHIBIT 99.1
WESTLAKE CHEMICAL PARTNERS LP

Contact—(713) 585-2900
Investors—Steve Bender
Media—L. Benjamin Ederington


Westlake Chemical Partners LP Announces Third Quarter 2024 Results
•Celebrated 10th anniversary as a publicly traded master limited partnership having grown the quarterly distribution 71% since IPO
•Declared quarterly distribution of $0.4714 per unit; 41st consecutive quarterly distribution
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2024 of $18.1 million, or $0.51 per limited partner unit, an increase of $4.9 million compared to the third quarter 2023 net income of $13.2 million. Cash flows from operating activities in the third quarter of 2024 were $126.1 million, an increase of $25.2 million compared to third quarter 2023 cash flows from operating activities of $100.9 million, due to higher net income. For the three months ended September 30, 2024, MLP distributable cash flow was $17.9 million, an increase of $4.3 million compared to third quarter 2023 MLP distributable cash flow of $13.6 million. The increase in MLP distributable cash flow and associated trailing twelve-month coverage ratio was due to higher net income in addition to lower maintenance capital expenditures.
Third quarter 2024 net income attributable to the Partnership of $18.1 million increased by $3.7 million compared to second quarter 2024 net income of $14.4 million, primarily due to higher third-party ethylene sales volume with higher margin on these sales. Third quarter 2024 cash flows from operating activities of $126.1 million increased by $4.2 million compared to second quarter 2024 cash flows from operating activities of $121.9 million. Third quarter 2024 MLP distributable cash flow of $17.9 million increased by $0.8 million compared to second quarter 2024 MLP distributable cash flow of $17.1 million, primarily due to the higher net income.
"We are pleased with the Partnership's performance for the third quarter of 2024. During the quarter, third-party ethylene sales prices and margins improved to their highest quarterly average in years, in part due to weather events and production outages at other producers. In an effort to better capture these attractive third-party margins we opportunistically made the decision to defer the planned turnaround at our Petro 1 ethylene unit to the first quarter of 2025 while also shifting third-party sales volumes planned for later in the year into the third quarter. As a result, we were pleased with the improvement in our third quarter distributable cash flow compared to recent quarters," said Jean-Marc Gilson, President and Chief Executive Officer. "Looking ahead to the remainder of 2024, with most of our planned third-party ethylene sales volumes for the year already booked, and as maintenance capital spending increases to support the upcoming Petro 1 turnaround in early 2025, we expect some moderation in our distributable cash flow in the fourth quarter. However, the improved outlook for third-party ethylene margins and continued execution of our ethylene sales contract with Westlake position us well for continued predictable cash flow and distributions to our unitholders, which we have demonstrated since our IPO ten years ago."
On October 30, 2024, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the third quarter of 2024 of $0.4714 per unit to be payable on November 27, 2024 to unitholders of record as of November 12, 2024, representing the 41st consecutive quarterly distribution to our unitholders. MLP distributable cash flow provided trailing twelve-month coverage of 1.03x the declared distributions for the third quarter of 2024, which was higher than the trailing twelve-month coverage ratio of 0.96x at the end of the second quarter of 2024. Since our IPO in July of 2014 our cumulative coverage ratio is 1.08x.
OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures.
i

The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to the timing of the anticipated Petro 1 turnaround, results of our turnaround reserves and activities, our future coverage ratio, our outlook for third-party ethylene margins, our expectations regarding feedstock and energy costs, the ability to deliver value, returns, predictable cash flows and distributions to unitholders, the expectation that strong distributions will continue, and the nature of the sales agreement with Westlake, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, operating difficulties; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake Corporation; actions of third parties; the timing and results of capital expenditures, including turnaround activities; inclement or hazardous weather conditions, including flooding, and the physical impacts of climate change; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; difficulty collecting receivables; inability of our customers to take delivery; fires, explosions or other industrial accidents; our ability to borrow funds and access capital markets; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC in February 2024, and the Partnership's Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, which was filed with the SEC in August 2024.

This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.

Use of Non-GAAP Financial Measures

This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of income, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake Corporation's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow, coverage ratio and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.

Westlake Chemical Partners LP
Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana, and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.
ii

Westlake Chemical Partners LP Conference Call Information:
A conference call to discuss Westlake Chemical Partners' third quarter 2024 results will be held Tuesday, November 5th, 2024 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, please register at: https://register.vevent.com/register/BId643f8e14d904c4dbc8954f14daeb022. A dial-in will be provided upon registration.
The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/sdd3kqrb and the earnings release can be obtained via the Partnership web page at: https://investors.wlkpartners.com/corporate-profile/default.aspx.
iii


WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS")
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(In thousands of dollars, except per unit data)
Revenue
Net sales—Westlake Corporation ("Westlake")$215,799 $289,303 $690,535 $771,349 
Net co-products, ethylene and other sales—third parties61,196 32,361 155,301 122,169 
Total net sales276,995 321,664 845,836 893,518 
Cost of sales160,052 228,683 525,481 606,742 
Gross profit116,943 92,981 320,355 286,776 
Selling, general and administrative expenses7,254 6,741 21,936 21,884 
Income from operations109,689 86,240 298,419 264,892 
Other income (expense)
Interest expense—Westlake(6,698)(6,437)(19,930)(19,869)
Other income, net1,325 1,272 3,916 3,153 
Income before income taxes104,316 81,075 282,405 248,176 
Provision for income taxes216 222 633 607 
Net income104,100 80,853 281,772 247,569 
Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP ("OpCo")85,964 67,647 234,376 207,585 
Net income attributable to Westlake Partners$18,136 $13,206 $47,396 $39,984 
Net income per limited partner unit attributable to Westlake Partners (basic and diluted)
Common units$0.51 $0.37 $1.35 $1.14 
Distributions declared per unit$0.4714 $0.4714 $1.4142 $1.4142 
MLP distributable cash flow$17,879 $13,620 $51,906 $46,156 
Distributions declared
Limited partner units—publicly and privately held$9,954 $9,949 $29,855 $29,841 
Limited partner units—Westlake6,657 6,658 19,971 19,973 
Total distributions declared$16,611 $16,607 $49,826 $49,814 
EBITDA$139,126 $115,738 $386,756 $349,947 

iv


WESTLAKE CHEMICAL PARTNERS LP
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
September 30,
2024		December 31,
2023
(In thousands of dollars)
ASSETS
Current assets
Cash and cash equivalents$60,208 $58,619 
Receivable under the Investment Management Agreement—Westlake109,540 94,444 
Accounts receivable, net—Westlake44,885 49,565 
Accounts receivable, net—third parties22,511 18,701 
Inventories3,751 4,432 
Prepaid expenses and other current assets667 442 
Total current assets241,562 226,203 
Property, plant and equipment, net908,992 943,843 
Other assets, net144,141 146,796 
Total assets$1,294,695 $1,316,842 
LIABILITIES AND EQUITY
Current liabilities (accounts payable and accrued and other liabilities)$53,291 $56,335 
Long-term debt payable to Westlake399,674 399,674 
Other liabilities3,916 4,583 
Total liabilities456,881 460,592 
Common unitholders—publicly and privately held472,296 473,513 
Common unitholder—Westlake48,020 48,993 
General partner—Westlake(242,572)(242,572)
Total Westlake Partners partners' capital277,744 279,934 
Noncontrolling interest in OpCo560,070 576,316 
Total equity837,814 856,250 
Total liabilities and equity$1,294,695 $1,316,842 
v


WESTLAKE CHEMICAL PARTNERS LP
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine Months Ended September 30,
20242023
(In thousands of dollars)
Cash flows from operating activities
Net income$281,772 $247,569 
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization84,421 81,902 
Net loss on disposition and other2,227 4,352 
Other balance sheet changes(15,888)10,505 
Net cash provided by operating activities352,532 344,328 
Cash flows from investing activities
Additions to property, plant and equipment(35,497)(33,979)
Investments with Westlake under the Investment Management Agreement(15,000)(164,116)
Maturities of investments with Westlake under the Investment Management Agreement— 145,000 
Net cash used for investing activities
(50,497)(53,095)
Cash flows from financing activities
Proceeds from debt payable to Westlake163,000 155,250 
Repayment of debt payable to Westlake(163,000)(155,250)
Distributions to noncontrolling interest retained in OpCo by Westlake(250,622)(240,333)
Distributions to unitholders(49,824)(49,813)
Net cash used for financing activities(300,446)(290,146)
Net increase in cash and cash equivalents
1,589 1,087 
Cash and cash equivalents at beginning of period58,619 64,782 
Cash and cash equivalents at end of period$60,208 $65,869 

vi


WESTLAKE CHEMICAL PARTNERS LP
RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME
AND NET CASH PROVIDED BY OPERATING ACTIVITIES
(Unaudited)
Three Months Ended June 30,Three Months Ended September 30,Nine Months Ended September 30,
20242024202320242023
(In thousands of dollars)
Net cash provided by operating activities$121,896 $126,071 $100,925 $352,532 $344,328 
Changes in operating assets and liabilities and other(33,870)(21,971)(20,072)(70,760)(96,759)
Net income88,026 104,100 80,853 281,772 247,569 
Add:
Depreciation, amortization and disposition of property, plant and equipment29,869 28,528 32,242 86,662 86,340 
Less:
Contribution to turnaround reserves(8,672)(11,903)(7,565)(32,051)(21,838)
Maintenance capital expenditures(9,306)(17,753)(22,862)(34,808)(37,407)
Distributable cash flow attributable to noncontrolling interest in OpCo(82,782)(85,093)(69,048)(249,669)(228,508)
MLP distributable cash flow$17,135 $17,879 $13,620 $51,906 $46,156 

vii

WESTLAKE CHEMICAL PARTNERS LP
RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH
PROVIDED BY OPERATING ACTIVITIES
(Unaudited)
Three Months Ended June 30,Three Months Ended September 30,Nine Months Ended September 30,
20242024202320242023
(In thousands of dollars)
Net cash provided by operating activities$121,896 $126,071 $100,925 $352,532 $344,328 
Changes in operating assets and liabilities and other(33,870)(21,971)(20,072)(70,760)(96,759)
Net income88,026 104,100 80,853 281,772 247,569 
Less:
Other income, net1,257 1,325 1,272 3,916 3,153 
Interest expense—Westlake(6,651)(6,698)(6,437)(19,930)(19,869)
Provision for income taxes(207)(216)(222)(633)(607)
Income from operations93,627 109,689 86,240 298,419 264,892 
Add:
Depreciation and amortization28,315 28,112 28,226 84,421 81,902 
Other income, net1,257 1,325 1,272 3,916 3,153 
EBITDA$123,199 $139,126 $115,738 $386,756 $349,947 

viii
v3.24.3
Cover Page
Nov. 05, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Nov. 05, 2024
Entity Registrant Name Westlake Chemical Partners LP
Entity Incorporation, State or Country Code DE
Entity File Number 001-36567
Entity Tax Identification Number 32-0436529
Entity Address, Address Line One 2801 Post Oak Boulevard,
Entity Address, Address Line Two Suite 600
Entity Address, City or Town Houston,
Entity Address, State or Province TX
Entity Address, Postal Zip Code 77056
City Area Code 713
Local Phone Number 585-2900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common units representing limited partnership interests
Trading Symbol WLKP
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0001604665
Amendment Flag false
Westlake Chemical Partners (NYSE:WLKP)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024 Haga Click aquí para más Gráficas Westlake Chemical Partners.
Westlake Chemical Partners (NYSE:WLKP)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024 Haga Click aquí para más Gráficas Westlake Chemical Partners.